{"id":"https://openalex.org/W4361945340","doi":"https://doi.org/10.1158/1078-0432.c.6524822","title":"Data from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC","display_name":"Data from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361945340","doi":"https://doi.org/10.1158/1078-0432.c.6524822"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6524822","doi":"https://doi.org/10.1158/1078-0432.c.6524822","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524822","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6524822","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058793243","display_name":"Hideho Okada","orcid":"https://orcid.org/0000-0003-0076-9920","observed_orcids":["https://orcid.org/0000-0003-0076-9920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideho Okada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026029856","display_name":"Lisa Helene Butterfield","orcid":"https://orcid.org/0000-0002-3439-9844","observed_orcids":["https://orcid.org/0000-0002-3439-9844"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa H. Butterfield","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002782232","display_name":"Ronald L. Hamilton","orcid":"https://orcid.org/0000-0002-6802-1102","observed_orcids":["https://orcid.org/0000-0002-6802-1102"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald L. Hamilton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062850215","display_name":"Aki Hoji","orcid":"https://orcid.org/0000-0001-7093-3437","observed_orcids":["https://orcid.org/0000-0001-7093-3437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aki Hoji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061817630","display_name":"Masashi Sakaki","orcid":"https://orcid.org/0000-0002-4431-3493","observed_orcids":["https://orcid.org/0000-0002-4431-3493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masashi Sakaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068121760","display_name":"Brian J. Ahn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian J. Ahn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022169733","display_name":"Gary Kohanbash","orcid":"https://orcid.org/0000-0002-3953-8022","observed_orcids":["https://orcid.org/0000-0002-3953-8022"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary Kohanbash","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091053515","display_name":"Jan Drappatz","orcid":"https://orcid.org/0000-0001-8187-7119","observed_orcids":["https://orcid.org/0000-0001-8187-7119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Drappatz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057531524","display_name":"Johnathan A. Engh","orcid":"https://orcid.org/0000-0003-4270-309X","observed_orcids":["https://orcid.org/0000-0003-4270-309X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnathan Engh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009622274","display_name":"Nduka Amankulor","orcid":"https://orcid.org/0000-0001-6217-1954","observed_orcids":["https://orcid.org/0000-0001-6217-1954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nduka Amankulor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025785938","display_name":"Mark O. Lively","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark O. Lively","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053414244","display_name":"Michael David Chan","orcid":"https://orcid.org/0000-0002-5278-6709","observed_orcids":["https://orcid.org/0000-0002-5278-6709"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D. Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110075395","display_name":"Andres M. Salazar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andres M. Salazar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103415116","display_name":"Edward G. Shaw","orcid":"https://orcid.org/0009-0004-2914-0119","observed_orcids":["https://orcid.org/0009-0004-2914-0119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward G. Shaw","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111991039","display_name":"Douglas M. Potter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas M. Potter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014264452","display_name":"Frank Scott Lieberman","orcid":"https://orcid.org/0000-0003-2577-3336","observed_orcids":["https://orcid.org/0000-0003-2577-3336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank S. Lieberman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7562999725341797,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7562999725341797,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.2379000037908554,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-grade-glioma","display_name":"low-grade glioma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/glioma-associated-antigens","display_name":"glioma-associated antigens","score":0.7450000047683716},{"id":"https://openalex.org/keywords/peptide-vaccine","display_name":"peptide vaccine","score":0.6439999938011169},{"id":"https://openalex.org/keywords/poly-iclc","display_name":"poly-ICLC","score":0.9599999785423279},{"id":"https://openalex.org/keywords/il-13-receptor-alpha-2","display_name":"IL-13 receptor alpha 2","score":0.7289999723434448},{"id":"https://openalex.org/keywords/epha2","display_name":"EphA2","score":0.9950000047683716},{"id":"https://openalex.org/keywords/wt1","display_name":"WT1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.8840000033378601},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7979999780654907},{"id":"https://openalex.org/keywords/hla-a2","display_name":"HLA-A2","score":0.7540000081062317},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5690000057220459},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.6549999713897705},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7580000162124634},{"id":"https://openalex.org/keywords/recurrent-glioma","display_name":"recurrent glioma","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6965795159339905},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6042675375938416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5239341855049133},{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.4474669098854065},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4445610046386719},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.435647577047348},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.431460440158844},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38532835245132446},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3509223759174347},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3486306369304657}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6524822","doi":"https://doi.org/10.1158/1078-0432.c.6524822","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524822","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6524822.v1","doi":"https://doi.org/10.1158/1078-0432.c.6524822.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6524822.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6524822","doi":"https://doi.org/10.1158/1078-0432.c.6524822","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524822","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2140738072","https://openalex.org/W4234403201","https://openalex.org/W2333324411","https://openalex.org/W1982217527","https://openalex.org/W2137405984","https://openalex.org/W2308211810","https://openalex.org/W2519568203","https://openalex.org/W2584901082","https://openalex.org/W2915626738","https://openalex.org/W2314317809"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"WHO":[2,239],"grade":[3,135,240],"2":[4,215,241],"low-grade":[5],"gliomas":[6],"(LGG)":[7],"with":[8,35,46,71,101,134,210],"high":[9],"risk":[10],"factors":[11],"for":[12,38,98,131,219],"recurrence":[13],"are":[14,191],"mostly":[15],"lethal":[16],"despite":[17],"current":[18,228],"treatments.":[19],"We":[20],"conducted":[21],"a":[22],"phase":[23],"I":[24],"study":[25],"to":[26],"evaluate":[27],"the":[28,50,155,188],"safety":[29],"and":[30,74,85,93,116,121,139,161,167,199,233],"immunogenicity":[31],"of":[32,104,154,164,249],"subcutaneous":[33],"vaccinations":[34],"synthetic":[36],"peptides":[37,88],"glioma-associated":[39],"antigen":[40],"(GAA)":[41],"epitopes":[42,158],"in":[43,49,91,159,194,202,213,238],"HLA-A2+":[44],"adults":[45],"high-risk":[47],"LGGs":[48],"following":[51],"three":[52,153],"cohorts:":[53],"(i)":[54],"patients":[55,64,172],"without":[56,65],"prior":[57,66,72],"progression,":[58],"chemotherapy,":[59],"or":[60,68],"radiotherapy":[61],"(RT);":[62],"(ii)":[63],"progression":[67],"chemotherapy":[69],"but":[70],"RT;":[73],"(iii)":[75],"recurrent":[76],"patients.":[77,181,243],"Experimental":[78],"Design:":[79],"GAAs":[80],"were":[81,89],"IL13R\u03b12,":[82],"EphA2,":[83],"WT1,":[84],"Survivin.":[86],"Synthetic":[87],"emulsified":[90],"Montanide-ISA-51":[92],"given":[94],"every":[95],"3":[96,117,136,180,204],"weeks":[97],"eight":[99],"courses":[100],"intramuscular":[102],"injections":[103],"poly-ICLC,":[105],"followed":[106],"by":[107],"q12":[108],"week":[109],"booster":[110],"vaccines.":[111],"Results:":[112],"Cohorts":[113],"1,":[114,120],"2,":[115],"enrolled":[118],"12,":[119],"10":[122,160],"patients,":[123],"respectively.":[124,169],"No":[125],"regimen-limiting":[126],"toxicity":[127],"was":[128],"encountered":[129],"except":[130],"one":[132],"case":[133],"fever,":[137],"fatigue,":[138],"mood":[140],"disturbance":[141],"(cohort":[142],"1).":[143],"ELISPOT":[144],"assays":[145],"demonstrated":[146,173],"robust":[147,235],"IFN\u03b3":[148,176],"responses":[149,177,237],"against":[150],"at":[151],"least":[152],"four":[156],"GAA":[157],"4":[162],"cases":[163],"cohorts":[165],"1":[166,171,196],"3,":[168],"Cohort":[170],"significantly":[174],"higher":[175],"than":[178,221],"cohort":[179,195,203,214],"Median":[182],"progression-free":[183,218],"survival":[184],"(PFS)":[185],"periods":[186],"since":[187,224],"first":[189],"vaccine":[190],"17":[192],"months":[193,201,223],"(range,":[197,205],"10\u201347+)":[198],"12":[200],"3\u201341+).":[206],"The":[207,227],"only":[208],"patient":[209],"large":[211],"astrocytoma":[212],"has":[216],"been":[217],"more":[220],"67":[222],"diagnosis.":[225],"Conclusion:":[226],"regimen":[229],"is":[230],"well":[231],"tolerated":[232],"induces":[234],"GAA-specific":[236],"glioma":[242],"These":[244],"results":[245],"warrant":[246],"further":[247],"evaluations":[248],"this":[250],"approach.":[251],"Clin":[252],"Cancer":[253],"Res;":[254],"21(2);":[255],"286\u201394.":[256],"\u00a92014":[257],"AACR.":[258]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}